HSA | FSA CARDS ARE NOW ACCEPTED

Written by Jay Hastings | Reviewed by Jayden Lee, PharmD | May 14, 2026

PlexusDx Education Hub: Browse all GLP-1 guides →

GLP-1 therapy options continue to expand, giving providers and patients more ways to personalize treatment. PlexusDx connects patients with licensed providers and offers six protocol options starting at $129/month from licensed 503A compounding pharmacies.

Introduction

Introduction is a key consideration for individuals exploring GLP-1 therapy. Clinical evidence supports a personalized approach guided by medical history and metabolic goals.

PlexusDx offers six GLP-1 protocols from licensed 503A compounding pharmacies. A provider consultation helps determine the most appropriate option for your situation.

The Science Behind Tirzepatide:

The Science Behind Tirzepatide: is a key consideration for individuals exploring GLP-1 therapy. Clinical evidence supports a personalized approach guided by medical history and metabolic goals.

PlexusDx offers six GLP-1 protocols from licensed 503A compounding pharmacies. A provider consultation helps determine the most appropriate option for your situation.

Dual Agonism: GLP-1 and GIP

Dual Agonism: GLP-1 and GIP is a key consideration for individuals exploring GLP-1 therapy. Clinical evidence supports a personalized approach guided by medical history and metabolic goals.

PlexusDx offers six GLP-1 protocols from licensed 503A compounding pharmacies. A provider consultation helps determine the most appropriate option for your situation.

How it Works in the Body

How it Works in the Body is a key consideration for individuals exploring GLP-1 therapy. Clinical evidence supports a personalized approach guided by medical history and metabolic goals.

PlexusDx offers six GLP-1 protocols from licensed 503A compounding pharmacies. A provider consultation helps determine the most appropriate option for your situation.

Your genes influence how you respond to GLP-1 therapy. The PlexusDx Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights—revealing predispositions across FTO, GIPR, GLP1R, MC4R, and other key variants—so your provider can tailor your protocol from day one. Available as a $99 add-on or $298 standalone.

Get Started with Compounded Tirzepatide Injection

Compounded Tirzepatide Injection is available through PlexusDx starting at $229–$309/mo—no insurance required, serving all 50 states from licensed 503A compounding pharmacies.

Learn more about Compounded Tirzepatide Injection →

Frequently Asked Questions About What is a Normal Dose of Tirzepatide? Your Guide to Effective Dosing

What should I know about What is a Normal Dose of Tirzepatide? Your Guide t?

This topic is best discussed with a qualified healthcare provider who can review your medical history and goals. PlexusDx facilitates provider consultations as part of its GLP-1 program.

Does PlexusDx use 503A compounding pharmacies?

Yes. All PlexusDx medications are dispensed from licensed 503A compounding pharmacies—never 503B outsourcing facilities.

How does genetics affect GLP-1 response?

Variants like FTO rs9939609, GIPR rs1800437, and GLP1R rs6923761 can influence appetite regulation and receptor sensitivity. The PlexusDx Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights to support personalized provider conversations.

Related Reading

Disclaimer: Compounded medications are not FDA-approved drug products. PlexusDx connects patients with licensed providers who may prescribe compounded GLP-1 medications from 503A compounding pharmacies. Individual results vary.

Return to the PlexusDx Education Hub for more GLP-1 guides.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. PlexusDx services require a provider consultation. Individual results vary. Not all patients qualify. All medications dispensed from licensed 503A compounding pharmacies.

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.